Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS
- PMID: 30737793
- DOI: 10.1002/jso.25401
Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS
Abstract
New evidence and systemic therapies demand an updated analysis of chemotherapy for soft tissue sarcoma. We completed a meta-analysis of chemotherapy in localized STS, assessing OS, PFS, and local and distant recurrence (local recurrence-free survival [LRFS] and distant recurrence-free survival [DRFS]). Ten studies, totaling 3157 patients, were included. A pooled analysis for 5-year OS, progression-free survival, LRFS, and DRFS showed no benefit of chemotherapy over locoregional therapy alone for all-comers or site-specific STS. We make recommendations to improve outcome reporting and quality indices.
Keywords: chemotherapy; localized; resectable; soft tissue sarcoma.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.Cancer. 2008 Aug 1;113(3):573-81. doi: 10.1002/cncr.23592. Cancer. 2008. PMID: 18521899
-
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.Lancet. 1997 Dec 6;350(9092):1647-54. Lancet. 1997. PMID: 9400508
-
Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults.Cochrane Database Syst Rev. 2000;(4):CD001419. doi: 10.1002/14651858.CD001419. Cochrane Database Syst Rev. 2000. PMID: 11034717 Review.
-
Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC).Cochrane Database Syst Rev. 2000;2000(2):CD001419. doi: 10.1002/14651858.CD001419. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2000;(4):CD001419. doi: 10.1002/14651858.CD001419. PMID: 10796873 Free PMC article. Updated. Review.
-
Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) - A systematic review and meta-analysis.Cancer Treat Rev. 2018 Feb;63:71-78. doi: 10.1016/j.ctrv.2017.12.003. Epub 2017 Dec 6. Cancer Treat Rev. 2018. PMID: 29253836 Review.
Cited by
-
Primary leiomyosarcoma of the inferior vena cava in a pediatric case: a case report and literature review.Surg Case Rep. 2023 Apr 6;9(1):52. doi: 10.1186/s40792-023-01630-x. Surg Case Rep. 2023. PMID: 37022631 Free PMC article.
-
Isolated Limb Perfusion of Upper Limb: How I Do It.Indian J Surg Oncol. 2022 Dec;13(4):776-779. doi: 10.1007/s13193-022-01561-3. Epub 2022 Jun 3. Indian J Surg Oncol. 2022. PMID: 36687241 Free PMC article. No abstract available.
-
Prediction tools for the personalized management of soft-tissue sarcomas of the extremity.Bone Joint J. 2022 Sep;104-B(9):1011-1016. doi: 10.1302/0301-620X.104B9.BJJ-2022-0647. Bone Joint J. 2022. PMID: 36047022 Free PMC article. Review.
-
Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas-Looking Forward.Cancers (Basel). 2022 Apr 5;14(7):1831. doi: 10.3390/cancers14071831. Cancers (Basel). 2022. PMID: 35406603 Free PMC article. Review.
-
Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma.Cancers (Basel). 2022 Jan 17;14(2):448. doi: 10.3390/cancers14020448. Cancers (Basel). 2022. PMID: 35053609 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
